{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T15:12:14Z","timestamp":1784041934941,"version":"3.55.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T00:00:00Z","timestamp":1779148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T00:00:00Z","timestamp":1783987200000},"content-version":"vor","delay-in-days":56,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-026-13604-z","type":"journal-article","created":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T06:16:00Z","timestamp":1779171360000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Adjunctive linezolid in patients with tuberculous meningitis for the prevention of mortality or neurologic disability: a meta-analysis of randomized controlled trials"],"prefix":"10.1186","volume":"26","author":[{"given":"Gabriel Moreira","family":"Lino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pauliana Val\u00e9ria Machado","family":"Galv\u00e3o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jurandy J\u00fanior Ferraz","family":"Magalh\u00e3es","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George Alessandro Maranh\u00e3o","family":"Conrado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,19]]},"reference":[{"key":"13604_CR1","doi-asserted-by":"publisher","first-page":"3482","DOI":"10.1007\/s00415-022-11052-8","volume":"269","author":"A Navarro-Flores","year":"2022","unstructured":"Navarro-Flores A, Fernandez-Chinguel JE, Pacheco-Barrios N, Soriano-Moreno DR, Pacheco-Barrios K. Global morbidity and mortality of central nervous system tuberculosis: a systematic review and meta-analysis. J Neurol. 2022;269:3482\u201394. https:\/\/doi.org\/10.1007\/s00415-022-11052-8.","journal-title":"J Neurol"},{"key":"13604_CR2","doi-asserted-by":"publisher","unstructured":"Leonard JM. Central nervous system tuberculosis. Microbiol Spectr. 2017;5. https:\/\/doi.org\/10.1128\/microbiolspec.tnmi7-0044-2017.\u00a0","DOI":"10.1128\/microbiolspec.tnmi7-0044-2017"},{"key":"13604_CR3","doi-asserted-by":"publisher","first-page":"ofaa257","DOI":"10.1093\/ofid\/ofaa257","volume":"7","author":"AM Stadelman","year":"2020","unstructured":"Stadelman AM, Ellis J, Samuels THA, Mutengesa E, Dobbin J, Ssebambulidde K, Rutakingirwa MK, Tugume L, Boulware DR, Grint D, Cresswell FV. Treatment Outcomes in Adult Tuberculous Meningitis: A Systematic Review and Meta-analysis. Open Forum Infect Dis. 2020;7:ofaa257. https:\/\/doi.org\/10.1093\/ofid\/ofaa257.","journal-title":"Open Forum Infect Dis"},{"key":"13604_CR4","volume-title":"Linezolid","author":"A Azzouz","year":"2024","unstructured":"Azzouz A, Preuss CV. Linezolid. Treasure Island (FL): In: StatPearls. StatPearls Publishing; 2024."},{"key":"13604_CR5","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1056\/NEJMoa1901814","volume":"382","author":"F Conradie","year":"2020","unstructured":"Conradie F, Diacon AH, Ngubane N, Howell P, Everitt D, Crook AM, Mendel CM, Egizi E, Moreira J, Timm J, McHugh TD, Wills GH, Bateson A, Hunt R, Van Niekerk C, Li M, Olugbosi M, Spigelman M, Nix, -TB Trial Team. Treatment of Highly Drug-Resistant Pulmonary Tuberculosis. N Engl J Med. 2020;382:893\u2013902. https:\/\/doi.org\/10.1056\/NEJMoa1901814.","journal-title":"N Engl J Med"},{"key":"13604_CR6","doi-asserted-by":"publisher","unstructured":"Conradie Francesca, Bagdasaryan Tatevik R, Sergey B, Pauline H, Lali M, Nosipho N, Anastasia S, Sergey S, Elena T, Ebrahim V, Petr Y, Daniel E, Wills Genevieve H, Eugene S, Olugbosi Morounfolu, Egizi Erica, Li Mengchun, Holsta Alda, Timm Juliano, Bateson Anna, Crook Angela M, Fabiane Stella M, Robert H, McHugh, Timothy D, Tweed Conor D, Salah F, Carl M. M. Spigelman melvin bedaquiline\u2013pretomanid\u2013linezolid regimens for drug-resistant tuberculosis. N Engl J Med. 2022;387:810\u2013823. https:\/\/doi.org\/10.1056\/NEJMoa2119430","DOI":"10.1056\/NEJMoa2119430"},{"key":"13604_CR7","unstructured":"World Health Organization. WHO consolidated guidelines on tuberculosis: module 4: treatment: drug-susceptible tuberculosis treatment. 2022. https:\/\/www.who.int\/publications-detail-redirect\/9789240048126. Accessed 6 Jan 2024."},{"key":"13604_CR8","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1186\/s12879-021-06705-4","volume":"21","author":"M-T Fang","year":"2021","unstructured":"Fang M-T, Su Y-F, An H-R, Zhang P-Z, Deng G-F, Liu H-M, Mao Z, Zeng J-F, Li G, Yang Q-T, Wang Z-Y. Decreased mortality seen in rifampicin\/multidrug-resistant tuberculous meningitis treated with linezolid in Shenzhen, China. BMC Infect Dis. 2021;21:1015. https:\/\/doi.org\/10.1186\/s12879-021-06705-4.","journal-title":"BMC Infect Dis"},{"key":"13604_CR9","doi-asserted-by":"publisher","first-page":"6297","DOI":"10.1128\/AAC.02784-14","volume":"58","author":"F Sun","year":"2014","unstructured":"Sun F, Ruan Q, Wang J, Chen S, Jin J, Shao L, Zhang Y, Zhang W. Linezolid Manifests a Rapid and Dramatic Therapeutic Effect for Patients with Life-Threatening Tuberculous Meningitis. Antimicrob Agents Chemother. 2014;58:6297\u2013301. https:\/\/doi.org\/10.1128\/AAC.02784-14.","journal-title":"Antimicrob Agents Chemother"},{"key":"13604_CR10","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/s11904-023-00678-6","volume":"20","author":"S Kimuda","year":"2023","unstructured":"Kimuda S, Kasozi D, Namombwe S, Gakuru J, Mugabi T, Kagimu E, Rutakingirwa MK, Leon KE, Chow F, Wasserman S, Boulware DR, Cresswell FV, Bahr NC. Advancing Diagnosis and Treatment in People Living with HIV and Tuberculosis Meningitis. Curr HIV\/AIDS Rep. 2023;20:379\u201393. https:\/\/doi.org\/10.1007\/s11904-023-00678-6.","journal-title":"Curr HIV\/AIDS Rep"},{"key":"13604_CR11","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1128\/aac.46.3.936-937.2002","volume":"46","author":"P Villani","year":"2002","unstructured":"Villani P, Regazzi B, Marubbi M, Viale F, Pagani P, Cristini L, Cadeo F, Carosi B, Bergomi G R. Cerebrospinal Fluid Linezolid Concentrations in Postneurosurgical Central Nervous System Infections. Antimicrob Agents Chemother. 2002;46:936\u20137. https:\/\/doi.org\/10.1128\/aac.46.3.936-937.2002.","journal-title":"Antimicrob Agents Chemother"},{"key":"13604_CR12","doi-asserted-by":"publisher","first-page":"l4898","DOI":"10.1136\/bmj.l4898","volume":"366","author":"JAC Sterne","year":"2019","unstructured":"Sterne JAC, Savovi\u0107 J, Page MJ, Elbers RG, Blencowe NS, Boutron I, Cates CJ, Cheng H-Y, Corbett MS, Eldridge SM, Emberson JR, Hern\u00e1n MA, Hopewell S, Hr\u00f3bjartsson A, Junqueira DR, J\u00fcni P, Kirkham JJ, Lasserson T, Li T, McAleenan A, Reeves BC, Shepperd S, Shrier I, Stewart LA, Tilling K, White IR, Whiting PF, Higgins JPT. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019;366:l4898. https:\/\/doi.org\/10.1136\/bmj.l4898.","journal-title":"BMJ"},{"key":"13604_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v093.i06","volume":"93","author":"C R\u00f6ver","year":"2020","unstructured":"R\u00f6ver C. Bayesian Random-Effects Meta-Analysis Using the bayesmeta R Package. J Stat Softw. 2020;93:1\u201351. https:\/\/doi.org\/10.18637\/jss.v093.i06.","journal-title":"J Stat Softw"},{"key":"13604_CR14","doi-asserted-by":"crossref","unstructured":"Wolfgang Viechtbauer. Conducting meta-analyses in R with the metafor package. J Stat Softw. 2010;36","DOI":"10.18637\/jss.v036.i03"},{"key":"13604_CR15","unstructured":"Sch\u00fcnemann H, Bro\u017cek J, Guyatt G, Oxman A, editor(s). Handbook for grading the quality of evidence and the strength of recommendations using the GRADE approach (updated October 2013). 2013."},{"key":"13604_CR16","unstructured":"McMaster University and Evidence Prime. GRADEpro guideline development tool. Software. gradepro.org. GRADEpro GDT. 2024."},{"key":"13604_CR17","doi-asserted-by":"publisher","first-page":"102351","DOI":"10.1016\/j.tube.2023.102351","volume":"142","author":"A Sahib","year":"2023","unstructured":"Sahib A, Bhatia R, Srivastava MVP, Singh MB, Komakula S, Vishnu VY, Rajan R, Gupta A, Srivastava AK, Wig N, Vikram NK, Biswas A. Escalate: Linezolid as an add on treatment in the intensive phase of tubercular meningitis. A randomized controlled pilot trial. Tuberc Edinb Scotl. 2023;142:102351. https:\/\/doi.org\/10.1016\/j.tube.2023.102351.","journal-title":"Tuberc Edinb Scotl"},{"key":"13604_CR18","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1093\/cid\/ciac932","volume":"76","author":"AG Davis","year":"2022","unstructured":"Davis AG, Wasserman S, Stek C, Maxebengula M, Jason Liang C, Stegmann S, Koekemoer S, Jackson A, Kadernani Y, Bremer M, Daroowala R, Aziz S, Goliath R, Lai Sai L, Sihoyiya T, Denti P, Lai RPJ, Crede T, Naude J, Szymanski P, Vallie Y, Banderker IA, Moosa MS, Raubenheimer P, Candy S, Offiah C, Wahl G, Vorster I, Maartens G, Black J, Meintjes G, Wilkinson RJ. A Phase 2A Trial of the Safety and Tolerability of Increased Dose Rifampicin and Adjunctive Linezolid, With or Without Aspirin, for Human Immunodeficiency Virus\u2013Associated Tuberculous Meningitis: The LASER-TBM Trial. Clin Infect Dis Off Publ Infect Dis Soc Am. 2022;76:1412\u201322. https:\/\/doi.org\/10.1093\/cid\/ciac932.","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"key":"13604_CR19","doi-asserted-by":"publisher","first-page":"3265","DOI":"10.1212\/WNL.0000000000203147","volume":"100","author":"F Kibengo","year":"2023","unstructured":"Kibengo F, Kabarambi A, Kafeero P, Muhumuza P, Nakimbugwe M, Ssemaganda A, Tayebwa C, Nahid P, Cresswell F, Chow F. Safety and tolerability of adjunctive linezolid with high or standard dose rifampin for the treatment of adults with HIV-associated tuberculous meningitis in Uganda: preliminary findings from the ALTER trial (S25.003). Neurology. 2023;100:3265. https:\/\/doi.org\/10.1212\/WNL.0000000000203147.","journal-title":"Neurology"},{"key":"13604_CR20","doi-asserted-by":"publisher","unstructured":"Haigh KA, Twabi HH, Boloko L, Namale PE, Lutje V, Nevitt S, Davies G. Efficacy and safety of higher dose rifampicin in adults with presumed drug-susceptible tuberculosis: an updated systematic review and meta-analysis. eClinical Medicine. 2024;77. https:\/\/doi.org\/10.1016\/j.eclinm.2024.102857","DOI":"10.1016\/j.eclinm.2024.102857"},{"key":"13604_CR21","doi-asserted-by":"publisher","first-page":"2434","DOI":"10.1056\/NEJMoa2502866","volume":"393","author":"DB Meya","year":"2025","unstructured":"Meya DB, Cresswell FV, Dai B, Engen N, Naidoo K, Ganiem AR, Imran D, Kabahubya M, Lessells RJ, Yunivita V, Estiasari R, Tugume L, Hlabisa B, Kurniawati MY, Sagita N, Kagimu E, Maharani K, Gakuru J, Gaharu MN, Mugabi T, Kimuda S, Namombwe S, te Brake L, Aarnoutse R, Svensson EM, Bangdiwala AS, Namanda S, Bahr NC, Musubire AK, Moosa MYS, Hamers RL, Marais S, Boulware DR, van Crevel R, Ruslami R. Trial of High-Dose Oral Rifampin in Adults with Tuberculous Meningitis. N Engl J Med. 2025;393:2434\u201346. https:\/\/doi.org\/10.1056\/NEJMoa2502866.","journal-title":"N Engl J Med"},{"key":"13604_CR22","unstructured":"World Health Organization. Global Tuberculosis Programme (GTB), the end TB strategy. 2015. https:\/\/www.who.int\/publications-detail-redirect\/WHO-HTM-TB-2015.19. Accessed 25 May 2024."},{"key":"13604_CR23","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.5114\/aoms\/189905","volume":"20","author":"X Liu","year":"2024","unstructured":"Liu X, Tang D, Qi M, He J-Q. Efficacy of linezolid in the treatment of tuberculous meningitis: a meta-analysis. Arch Med Sci. 2024;20:1038\u201342. https:\/\/doi.org\/10.5114\/aoms\/189905.","journal-title":"Arch Med Sci"},{"key":"13604_CR24","doi-asserted-by":"publisher","first-page":"e0000069","DOI":"10.1371\/journal.pgph.0000069","volume":"1","author":"PJ Dodd","year":"2021","unstructured":"Dodd PJ, Osman M, Cresswell FV, Stadelman AM, Lan NH, Thuong NTT, Muzyamba M, Glaser L, Dlamini SS, Seddon JA. The global burden of tuberculous meningitis in adults: A modelling study. PLOS Glob Public Health. 2021;1:e0000069. https:\/\/doi.org\/10.1371\/journal.pgph.0000069.","journal-title":"PLOS Glob Public Health"},{"key":"13604_CR25","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1186\/s13054-018-2140-8","volume":"22","author":"M Cantier","year":"2018","unstructured":"Cantier M, Morisot A, Gu\u00e9rot E, Megarbane B, Razazi K, Contou D, Mariotte E, Canet E, De Montmollin E, Dub\u00e9e V, Boulet E, Gaudry S, Voiriot G, Mayaux J, P\u00e8ne F, Neuville M, Mourvillier B, Ruckly S, Bouadma L, Wolff M, Timsit J-F, Sonneville R. Functional outcomes in adults with tuberculous meningitis admitted to the ICU: a multicenter cohort study. Crit Care. 2018;22:210. https:\/\/doi.org\/10.1186\/s13054-018-2140-8.","journal-title":"Crit Care"},{"key":"13604_CR26","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1186\/s12879-025-10874-x","volume":"25","author":"Z-T Fei","year":"2025","unstructured":"Fei Z-T, Huang W, Zhou D-P, Yang Y, Liu P, Gan N, He P-P, Ye D, Liu H-R, Liu X-H, Xia L. Clinical efficacy of linezolid in the treatment of tuberculous meningitis: a retrospective analysis and literature review. BMC Infect Dis. 2025;25:467. https:\/\/doi.org\/10.1186\/s12879-025-10874-x.","journal-title":"BMC Infect Dis"},{"key":"13604_CR27","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1093\/infdis\/jiad413","volume":"229","author":"N Abdelgawad","year":"2024","unstructured":"Abdelgawad N, Wasserman S, Abdelwahab MT, Davis A, Stek C, Wiesner L, Black J, Meintjes G, Wilkinson RJ, Denti P. Linezolid Population Pharmacokinetic Model in Plasma and Cerebrospinal Fluid Among Patients With Tuberculosis Meningitis. J Infect Dis. 2024;229:1200\u20138. https:\/\/doi.org\/10.1093\/infdis\/jiad413.","journal-title":"J Infect Dis"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-026-13604-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-13604-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-13604-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T15:03:11Z","timestamp":1784041391000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12879-026-13604-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,19]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["13604"],"URL":"https:\/\/doi.org\/10.1186\/s12879-026-13604-z","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,19]]},"assertion":[{"value":"18 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1320"}}